C1QTNF9 and hyperhomocysteinemia: CTRP9 may be a potential therapeutic target for the prevention and treatment of hyperhomocysteinemia and As, providing a theoretical basis for the study of the pathogenesis of Hcy-induced As and the prevention and treatment of hyperhomocysteinemia and As (Supplementary Information).